Inari Medical, Inc.
NARI · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$18,367 | -$31,348 | -$24,202 | -$4,667 |
| Dep. & Amort. | $5,384 | $4,737 | $4,616 | $2,160 |
| Deferred Tax | $0 | $0 | $0 | -$584 |
| Stock-Based Comp. | $12,951 | $13,039 | $12,870 | $9,801 |
| Change in WC | -$7,229 | $19,024 | -$11,352 | $9,542 |
| Other Non-Cash | $9,973 | $32,695 | $6,325 | -$4,011 |
| Operating Cash Flow | $2,712 | $11,513 | -$12,288 | $12,241 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,409 | -$4,580 | -$1,910 | -$2,400 |
| Net Acquisitions | $0 | $3,722 | $0 | -$240,419 |
| Inv. Purchases | -$52,047 | -$17,537 | -$21,501 | -$11,677 |
| Inv. Sales/Matur. | $21,501 | $12,634 | $62,573 | $194,780 |
| Other Inv. Act. | -$2,298 | $3,722 | -$660 | $181,612 |
| Investing Cash Flow | -$34,253 | -$5,761 | $39,162 | -$59,716 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$4,081 | $98 | $3,983 | $1 |
| Stock Repurch. | $8,132 | -$2,851 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,386 | -$2,753 | -$2,968 | -$2,411 |
| Financing Cash Flow | $2,386 | -$2,753 | $1,015 | -$2,410 |
| Forex Effect | $171 | -$14 | $110 | -$89 |
| Net Chg. in Cash | -$28,984 | $2,985 | $27,999 | -$49,974 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $70,192 | $67,207 | $39,208 | $89,182 |
| End Cash | $41,208 | $70,192 | $67,207 | $39,208 |
| Free Cash Flow | -$995 | $6,933 | -$14,198 | $9,841 |